Bio Rad Laboratories Inc (NYSE:BIO) over-valued by 16%
| Website | http://www.bio-rad.com/ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $17,865,717,760 |
| Beta | 1.05552 |
| Average Volume | $214,650 |
| Last Dividend | 0% |
| Price on Sep 30, 2020 | $602.57 |
| Autochartist™ Valuation | $508.75 |
| Conclusion |
16% over-valued |
| Download Report |
